Skip to main content

Thiopurine Methyltransferase Activity and Efficacy of Azathioprine Immunosuppression in Transplant Recipients

  • Chapter
Purine and Pyrimidine Metabolism in Man VII

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 309A))

Abstract

Azathioprine (AZA) has been given to transplanted patients since 1963 (1), but despite extensive use its metabolism is still not completely understood. After oral administration, it is converted rapidly to 6-mercaptopurine (6MP), mainly in the liver and the gut (2). 6MP is metabolised by three competing pathways (Figure 1): A) conversion to 6-thioinosinic acid by hypoxanthine guanine phosphoribosyltransferase (HPRT) and thence thioguanine nucleotides which exert their cytotoxicity by incorporation into DNA and RNA (2,3); B) catabolism by xanthine oxidase (XOD) to 6-thiouric acid; C) conversion to 6-methyl mercaptopurine (6MeMP) by the enzyme thiopurine methyl transferase (TPMT), which has a wide range of activity in the normal population and is inherited in a autosomal codominant fashion (3,4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J.E. Murray, J.P Merrill, J.H. Harrison, R.E. Wilson and G.J. Dammin, Prolonged survival of human-kidney homografts by iramunosuppressive drug therapy. N Engl J Med 268:1315 (1963).

    Article  PubMed  CAS  Google Scholar 

  2. D.M. Tidd and A.R.P. Paterson. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res 34:738 (1974).

    PubMed  CAS  Google Scholar 

  3. R.M. Weinshilboum and S.L. Sladek. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Hum Genet 32:651 (1980).

    CAS  Google Scholar 

  4. L. Lennard, J.A. Van Loon and R.M. Weinshilboum. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine raethyltransferase genetic polymorphism. Clin Pharmacol Ther 46:149 (1989).

    Article  PubMed  CAS  Google Scholar 

  5. R.M. Weinshilboum, F.A. Raymond and P.A. Pazmino. Human erythrocyte thiopurine raethyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 85:323 (1978).

    Article  PubMed  CAS  Google Scholar 

  6. C.A. Rees, L. Lennard, J.S. Lilleyman and J.L. Maddocks. Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukaemia. Cancer Chemother Pharmacol 12:87 (1984).

    Article  PubMed  CAS  Google Scholar 

  7. G.L.C. Chan, G.R. Erdmann, S.A. Gruber, A.J. Matas and D.M. Canafax. Azathioprine metabolism: Pharmacokinetics of 6-mercaptopurine, 6-thiouric and 6-thioguanine nucleotides in renal transplant patients. J Clin Pharmacol 30: 358 (1990).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chocair, P.R., Duley, J.A., Simmonds, H.A., Cameron, J.S. (1991). Thiopurine Methyltransferase Activity and Efficacy of Azathioprine Immunosuppression in Transplant Recipients. In: Harkness, R.A., Elion, G.B., Zöllner, N. (eds) Purine and Pyrimidine Metabolism in Man VII. Advances in Experimental Medicine and Biology, vol 309A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2638-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2638-8_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-2640-1

  • Online ISBN: 978-1-4899-2638-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics